Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Vaccine Tests Back on Again, Stocks Hike

GILD

Stocks rose on Monday, led by tech, amid a slew of corporate dealmaking activity as the market tried to recover from its first back-to-back weekly declines in months.

The Dow Jones Industrials rocketed 370.44 points, or 1.3%, to break for lunch at 28,036.08

The S&P 500 climbed 56.54 points, or 1.7%, to 3,397.51.

The tech-heavy NASDAQ zoomed 246.4 points, or 2.3%, to 11,101.22.

Shares of Apple were higher by 2.8%. The market has been following in the footsteps of its rally leader. Apple shares are down 11% this month.

Tesla shares rebounded by more than 4%. The once-surging stock is down more than 25% in September after it failed to gain entry into the benchmark S&P 500, something investors were anticipating.

Tech sentiment was lifted by news of Nvidia buying chipmaker Arm Holdings from SoftBank for $40 billion. Nvidia will finance the deal through a combination of cash and common stock. Nvidia was up 8%. Other chipmakers also gained, including AMD, Micron and Skyworks.

Meanwhile, ByteDance rejected Microsoft's bid to buy TikTok's U.S. operations. Instead, ByteDance has chosen Oracle to be TikTok's U.S. technology partner, and Oracle will take a significant stake in the business, according to a person familiar with the discussions. Oracle shares were up 4.8%.

Outside of tech, Gilead said it will acquire Immunomedics to expand its cancer treatments. It was a $21-billion cash deal. Immunomedics shares doubled. Shares of Immunomedics more than doubled in price on Monday.

Sentiment also got a boost as AstraZeneca resumed phase three trials for its coronavirus vaccine in the U.K. following a halt for safety concerns.

Prices for the 10-Year Treasury were unchanged, keeping yields at Friday's 0.67%.

Oil prices doffed 25 cents to $37.08 U.S. a barrel.

Gold prices moved higher $22.40 to $1,970.30 U.S. an ounce.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today